Dr. Alencar is an Associate Professor of Clinical Medicine and the Chief Medical Officer at University of Miami Sylvester Comprehensive Cancer Center. He is a member of the lymphoma program at Sylvester and the lymphoma committee at the Alliance for Clinical Trials in Oncology. As the hematology section lead for the Sylvester’s Global Oncology Program, Dr. Alencar serves as an important bridge to the United States for Latin American hematologists being a constant presence in meetings, lectures, as well as tumor board and second opinions. These collaborations have led to a large multinational study evaluating the impact of genetic changes and ancestry on outcomes of Hispanic patients with blood disorders.

Megan joined HealthTree as the Program Manager for CLL in 2022. She is the daughter of a blood cancer patient and has found a passion for helping support patients and caregivers to advance research for their cure and improve their quality of life.